review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Alan M Krensky | |
Yong-Tae Ahn | |||
P2860 | cites work | RFLAT-1: a new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes | Q22008771 |
The nuclear factor SPBP contains different functional domains and stimulates the activity of various transcriptional activators | Q24290281 | ||
Cell-specific translational control of transcription factor BTEB expression. The role of an upstream AUG in the 5'-untranslated region | Q24316288 | ||
A translational rheostat for RFLAT-1 regulates RANTES expression in T lymphocytes | Q24552529 | ||
Dynamic interplay of transcriptional machinery and chromatin regulates "late" expression of the chemokine RANTES in T lymphocytes | Q24674124 | ||
The isolation and sequence of a novel gene from a human functional T cell line | Q24682853 | ||
Novel Role of Toll-Like Receptor 3 in Hepatitis C-Associated Glomerulonephritis | Q27477518 | ||
Transcriptional regulation of RANTES expression in T lymphocytes | Q28141636 | ||
A human T cell-specific molecule is a member of a new gene family | Q28307933 | ||
Interleukin-1beta induction of the chemokine RANTES promoter in the human astrocytoma line CH235 requires both constitutive and inducible transcription factors | Q33893063 | ||
Chemokines, chemokine receptors, and allograft rejection | Q34241116 | ||
Chemokines: attractive mediators of the immune response | Q35031893 | ||
The glomerulosclerosis of aging in females: contribution of the proinflammatory mesangial cell phenotype to macrophage infiltration. | Q35103388 | ||
Granulysin | Q35538177 | ||
The role of tubulointerstitial inflammation | Q36064052 | ||
Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. | Q36097429 | ||
Multi-faceted strategies to combat disease by interference with the chemokine system | Q36113426 | ||
Chemokines provide the sustained inflammatory bridge between innate and acquired immunity | Q36168977 | ||
Kinetics of transcription factors regulating the RANTES chemokine gene reveal a developmental switch in nuclear events during T-lymphocyte maturation | Q36556757 | ||
T-lymphocyte-antigen interactions in transplant rejection | Q38139921 | ||
IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses. | Q40261030 | ||
CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration | Q40646095 | ||
Enhanced chemokine response in experimental acute Escherichia coli pyelonephritis in IL-1beta-deficient mice | Q40673518 | ||
Switching gears during T-cell maturation: RANTES and late transcription | Q41632956 | ||
High expression of chemokine gene as a favorable prognostic factor in renal cell carcinoma | Q45875161 | ||
Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. | Q45994384 | ||
Increased expression of chemokines in patients with Wegener's granulomatosis - modulating effects of methylprednisolone in vitro | Q46419664 | ||
Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF. | Q46425691 | ||
Chemokines, lymphocytes and viruses: what goes around, comes around | Q47933792 | ||
Chemokines in interstitial injury | Q48025919 | ||
Differential expression of beta-chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts. | Q51036331 | ||
Expression of the chemokine RANTES in pulmonary Wegener's granulomatosis. | Q52020712 | ||
RANTES chemokine expression in cell-mediated transplant rejection of the kidney. | Q52059077 | ||
Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease. | Q53589016 | ||
Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener's granulomatosis. | Q54764812 | ||
Risk of Diabetic Nephropathy in Type 1 Diabetes Is Associated With Functional Polymorphisms in RANTES Receptor Gene (CCR5): A Sex-Specific Effect | Q59632221 | ||
Upregulation of MHC class II, interferon-alpha and interferon-gamma receptor protein expression in HIV-associated nephropathy | Q60725478 | ||
In situ analysis of C-C chemokine mRNA in human glomerulonephritis | Q61863558 | ||
Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy | Q73322132 | ||
Th1/Th2 predominance and proinflammatory cytokines determine the clinicopathological severity of IgA nephropathy | Q73398100 | ||
RANTES and MCP-1 chemokine plasma levels in chronic renal transplant dysfunction and chronic renal failure | Q73430201 | ||
Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy | Q73557426 | ||
Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis | Q73794085 | ||
Expression of chemokines and their receptors in nephrotoxic serum nephritis | Q73914361 | ||
Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes | Q73928002 | ||
Chemokine expression in the obstructed kidney | Q74087497 | ||
Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases | Q74259530 | ||
Activated intrarenal transcription of CTL-effectors and TGF-beta1 in children with focal segmental glomerulosclerosis | Q77475008 | ||
Oxidative stress influences CC-chemokine levels in hemodialyzed patients | Q80038246 | ||
Acute sodium overload produces renal tubulointerstitial inflammation in normal rats | Q80217875 | ||
Polymorphisms in the promoter region of RANTES in Han Chinese and their relationship with systemic lupus erythematosus | Q80401240 | ||
Monocyte haptotaxis induced by the RANTES chemokine | Q80505523 | ||
Hepatitis intensified oxidative stress, MIP-1beta and RANTES plasma levels in uraemic patients | Q81065009 | ||
Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo/Mna rats | Q81343798 | ||
CC chemokines and chemokine receptors in IgA nephropathy (IgAN) and in non-IgA mesangial proliferative glomerulonephritis (MesProGN). the immunohistochemical comparative study | Q81589036 | ||
Messenger RNA expression of RANTES in the urinary sediment of patients with lupus nephritis | Q83935705 | ||
P433 | issue | 3 | |
P304 | page(s) | 164-170 | |
P577 | publication date | 2007-03-01 | |
P1433 | published in | Nature Clinical Practice Nephrology | Q15751618 |
P1476 | title | Mechanisms of disease: regulation of RANTES (CCL5) in renal disease | |
P478 | volume | 3 |
Q50630834 | A new method for classifying different phenotypes of kidney transplantation. |
Q35982758 | Abatacept Treatment Does Not Preserve Renal Function in the Streptozocin-Induced Model of Diabetic Nephropathy |
Q37357137 | Blood cell-derived RANTES mediates cerebral microvascular dysfunction, inflammation, and tissue injury after focal ischemia-reperfusion |
Q39377637 | C-C Motif Chemokine 5 Attenuates Angiotensin II-Dependent Kidney Injury by Limiting Renal Macrophage Infiltration |
Q92472314 | CCR5 Signaling Promotes Murine and Human Hematopoietic Regeneration following Ionizing Radiation |
Q56774723 | Chemokines as Potential Markers in Pediatric Renal Diseases |
Q37627006 | Chemokines as potential markers in pediatric renal diseases |
Q35553334 | Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity |
Q40099747 | De novo expression of circulating biglycan evokes an innate inflammatory tissue response via MyD88/TRIF pathways |
Q37305438 | Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy |
Q40775844 | Delivery of microRNA-146a with polyethylenimine nanoparticles inhibits renal fibrosis in vivo |
Q52836563 | Different Cytokine and Chemokine Expression Patterns in Malignant Compared to Those in Nonmalignant Renal Cells. |
Q53055638 | Early Macrophage Infiltration and Sustained Inflammation in Kidneys From Deceased Donors Are Associated With Long-Term Renal Function. |
Q53654964 | Effect of salvianolic acid A and C compatibility on inflammatory cytokines in rats with unilateral ureteral obstruction. |
Q35278760 | Effects of the mTOR inhibitor rapamycin on monocyte-secreted chemokines |
Q36194247 | Fbw7γ-mediated degradation of KLF13 prevents RANTES expression in resting human but not murine T lymphocytes. |
Q39657367 | Hepatic steatosis causes induction of the chemokine RANTES in the absence of significant hepatic inflammation. |
Q36734848 | Hepatocyte growth factor exerts its anti-inflammatory action by disrupting nuclear factor-kappaB signaling |
Q37439709 | Holocarboxylase synthetase catalyzes biotinylation of heat shock protein 72, thereby inducing RANTES expression in HEK-293 cells. |
Q30414752 | Identification of biomarkers to assess organ quality and predict posttransplantation outcomes. |
Q91936584 | Immunohistological staining of unknown chemokine RANTES/CCL5 expression in jawbone marrow defects-osteoimmunology and disruption of bone remodeling in clinical case studies targeting on predictive preventive personalized medicine |
Q38102877 | In vivo regulation of chemokine activity by post-translational modification. |
Q34606146 | Inhibition of proinflammatory RANTES expression by TGF-beta1 is mediated by glycogen synthase kinase-3beta-dependent beta-catenin signaling |
Q33677002 | Intrapersonal and populational heterogeneity of the chemokine RANTES |
Q37297567 | Intravenous tolerance modulates macrophage classical activation and antigen presentation in experimental autoimmune encephalomyelitis |
Q98224230 | KLF6 Acetylation Promotes Sublytic C5b-9-Induced Production of MCP-1 and RANTES in Experimental Mesangial Proliferative Glomerulonephritis |
Q28511036 | Kruppel-like zinc finger protein Glis2 is essential for the maintenance of normal renal functions |
Q37973719 | Krüppel-like factors in lymphocyte biology |
Q33792541 | Mechanistic connection between inflammation and fibrosis |
Q27334808 | Microfluidic mazes to characterize T-cell exploration patterns following activation in vitro. |
Q28822270 | Mining kidney toxicogenomic data by using gene co-expression modules |
Q63815460 | Monocyte-predominant engraftment, cytokine levels and early transplant-related complications in pediatric hematopoietic stem cell recipients |
Q92942740 | Nano-sized carriers in gene therapy for renal fibrosis in vivo |
Q36010095 | New insights into epithelial-mesenchymal transition in kidney fibrosis |
Q28581020 | Opposite action of peroxisome proliferator-activated receptor-gamma in regulating renal inflammation: functional switch by its ligand |
Q36842418 | Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling |
Q39072710 | Perivascular adipose tissue inflammation in vascular disease |
Q39628035 | Porcine reproductive and respiratory syndrome virus (PRRSV) infection activates chemokine RANTES in MARC-145 cells |
Q46659186 | Pretreatment with paricalcitol attenuates inflammation in ischemia-reperfusion injury via the up-regulation of cyclooxygenase-2 and prostaglandin E2. |
Q85118805 | RANTES Deficiency Attenuates Autoantibody-Induced Glomerulonephritis |
Q36423403 | RANTES mediates kidney ischemia reperfusion injury through a possible role of HIF-1α and LncRNA PRINS. |
Q35849317 | Rantes/Ccl5 influences hematopoietic stem cell subtypes and causes myeloid skewing |
Q34787157 | Regulation of CC ligand 5/RANTES by acid sphingomyelinase and acid ceramidase |
Q41911498 | Regulation of chemokine CCL5 synthesis in human peritoneal fibroblasts: a key role of IFN-γ. |
Q89486486 | Resistant starch supplementation attenuates inflammation in hemodialysis patients: a pilot study |
Q43530084 | Rho kinase inhibition attenuates LPS-induced renal failure in mice in part by attenuation of NF-kappaB p65 signaling. |
Q38369393 | Role of angiotensin II and oxidative stress in renal inflammation by hypernatremia: benefits of atrial natriuretic peptide, losartan, and tempol |
Q37189621 | Sphingosine kinase 1 regulates tumor necrosis factor-mediated RANTES induction through p38 mitogen-activated protein kinase but independently of nuclear factor κB activation |
Q28482696 | Suramin alleviates glomerular injury and inflammation in the remnant kidney |
Q100428151 | Targeting a positive regulatory loop in the tumor-macrophage interaction impairs the progression of clear cell renal cell carcinoma |
Q28541530 | Temporal profile of the renal transcriptome of HIV-1 transgenic mice during disease progression |
Q34146504 | The Fli-1 transcription factor regulates the expression of CCL5/RANTES |
Q35888486 | Tubular cell dedifferentiation and peritubular inflammation are coupled by the transcription regulator Id1 in renal fibrogenesis |
Q42231646 | Tumor necrosis factor-α synergistically enhances polyinosinic-polycytidylic acid-induced toll-like receptor 3 signaling in cultured normal human mesangial cells: possible involvement in the pathogenesis of lupus nephritis |
Q34326473 | Uric acid induces renal inflammation via activating tubular NF-κB signaling pathway |
Search more.